Oxford Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Oxford Asset Management’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-65,502	Closed	-$742K	–	1838
2019 Q1	$742K	Buy	+65,502	New	+$732K	0.02%	1067
2018 Q4	–	Sell	-96,266	Closed	-$1.49M	–	1925
2018 Q3	$1.49M	Buy	+96,266	New	+$1.52M	0.03%	822
2018 Q2	–	Sell	-84,963	Closed	-$1.1M	–	1806
2018 Q1	$1.1M	Buy	84,963 +60,407	+246%	+$753K	0.02%	900
2017 Q4	$311K	Buy	+24,556	New	+$321K	0.01%	1326
2017 Q1	–	Sell	-131,670	Closed	-$1.69M	–	1431
2016 Q4	$1.69M	Sell	131,670 -336,355	-72%	-$4.25M	0.06%	371
2016 Q3	$6.22M	Buy	468,025 +378,856	+425%	+$4.43M	0.19%	125
2016 Q2	$976K	Sell	89,169 -150,565	-63%	-$1.47M	0.03%	490
2016 Q1	$2.2M	Sell	239,734 -187,115	-44%	-$1.54M	0.06%	357
2015 Q4	$4.24M	Buy	+426,849	New	+$4.13M	0.1%	221

Other funds holding IRWD

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return

Oxford Asset Management's IRWD Position: Q2 2019 in Review

Oxford Asset Management sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2019, closing a stake of 65,502 shares — an estimated $742K sold.

Oxford Asset Management first reported a position in IRWD in Q4 2015 and held it in 9 quarters. The position peaked at $6.22M in Q3 2016. 152 funds tracked by Wall St. Rank hold IRWD as of Q2 2019.

Oxford Asset Management reported no remaining Ironwood Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
Oxford Asset Management sold 65,502 Ironwood Pharmaceuticals shares in Q2 2019, an estimated $742K.
Oxford Asset Management first reported a position in Ironwood Pharmaceuticals in Q4 2015 and held it in 9 quarters.
Oxford Asset Management's Ironwood Pharmaceuticals position peaked at $6.22M in Q3 2016.
152 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2019.

Based on Oxford Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.